Clinical Trial Update: Chemotherapy Followed by Infusion of Partially HLA Matched Unrelated Donor Cells for Patients With AML Who Are Ineligible for Stem Cell Transplantation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating chemotherapy followed by infusion of partially HLA-matched unrelated donor cells in patients with acute myeloid leukemia who a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: University of Sydney | Conditions: Acute Myeloid Leukaemia | Phase 1 | Status: UNKNOWN